Interní Med. 2016; 18(4): 191-193 | DOI: 10.36290/int.2016.043
Generics and their therapeutic position, the risk of substitution in pharmacies
- Farmakologický ústav 1. lékařské fakulty Univerzity Karlovy v Praze
Therapeutic position of generics is frequently discussed. Physicians of various fields often question whether they are as effective
and safe for their patients as the original drug. The aim of the article is to summarize the problematics, from the development to
the practical impact on disease management in accordance with current knowledge, with an explanation of some ambiguities.
Keywords: generic, brand, bioequivalence, efficacy, safety
Published: September 1, 2016 Show citation
References
- Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, et al. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Ann Pharmacother. 2009; 43(10): 1583-1597.
Go to original source... 
Go to PubMed... - Manzoli L, Flacco ME, Boccia S, D'Andrea E, Panic N, Marzuillo C, et al. Generic versus brand-name drugs used in cardiovascular diseases. Eur J Epidemiol. 2015. Go to original source...
- Corrao G, Soranna D, Merlino L, Mancia G. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study. Eur J Clin Invest. 2014; 44(10): 933-939. Go to original source... Go to PubMed...
- Panahi Y, Pishgoo B, Dadjou Y, Mehdirad M, Soflaei SS, Sahebkar A. Efficacy and Safety of Dorocontin((R)) versus Sustac((R)) in the Treatment of Stable Angina Pectoris: A Randomized, Double-Blind Comparative Trial. Sci Pharm. 2014; 82(4): 815-824. Go to original source... Go to PubMed...